Patent details
EP3156422
Title:
HIGH AFFINITY HUMAN ANTIBODIES TO PCSK9
Basic Information
- Publication number:
- EP3156422
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP162003057
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- HIGH AFFINITY HUMAN ANTIBODIES TO PCSK9
- French Title of Invention:
- ANTICORPS HUMAINS À GRANDE AFFINITÉ POUR LE PCSK9
- German Title of Invention:
- HOCHAFFINE MENSCHLICHE ANTIKÖRPER GEGEN PCSK9
- SPC Number:
-
Dates
- Filing date:
- 15/12/2009
- Grant date:
- 25/08/2021
- EP Publication Date:
- 19/04/2017
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 25/08/2021
- EP B1 Publication Date:
- 25/08/2021
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 15/12/2029
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 18/08/2021
-
-
- Name:
- Regeneron Pharmaceuticals, Inc.
- Address:
- 777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)
Agent
- Name:
- ARONOVA S.A.
- From:
- 24/11/2021
- Address:
- PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
- To:
Inventor
1
- Name:
- HUANG, Tammy, T.
- Address:
- United States (US)
2
- Name:
- MACDONALD, Douglas
- Address:
- United States (US)
3
- Name:
- MARTIN, Joel H.
- Address:
- United States (US)
4
- Name:
- SLEEMAN, Mark W.
- Address:
- Australia (AU)
Priority
1
- Priority Number:
- 122482 P
- Priority Date:
- 15/12/2008
- Priority Country:
- United States (US)
2
- Priority Number:
- 210566 P
- Priority Date:
- 18/03/2009
- Priority Country:
- United States (US)
3
- Priority Number:
- 168753 P
- Priority Date:
- 13/04/2009
- Priority Country:
- United States (US)
4
- Priority Number:
- 218136 P
- Priority Date:
- 18/06/2009
- Priority Country:
- United States (US)
5
- Priority Number:
- 249135 P
- Priority Date:
- 06/10/2009
- Priority Country:
- United States (US)
6
- Priority Number:
- 261776 P
- Priority Date:
- 17/11/2009
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
C07K 16/40;
C12N 9/64;
A61K 39/395;
A61P 3/06;
Publication
European Patent Bulletin
- Issue number:
- 202134
- Publication date:
- 25/08/2021
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 31/12/2025
- Annual Fee Number:
- 17
- Annual Fee Amount:
- 246 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 28/11/2024
- Last Annual Fee Paid Number:
- 16
- Last Annual Fee Paid Amount:
- 230 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM